Home » Topics » Regulatory » Patents

Patents
RSS

Agents with affinity for dopamine and 5-HT1A receptors in development at Duphar

April 26, 1999

Coumarin derivatives with antiviral activity against HIV from Pliva

April 26, 1999

Lilly develops new antioxidants with particular utility as neuroprotectants

April 26, 1999

SS Pharm. presents new AGE inhibitors for use in diabetic complications

April 26, 1999

Selective 5-HT1A ligands described by ADIR in recent patent

April 26, 1999

BASF claims series with mixed ETA/ETB-antagonist properties

April 26, 1999

HDL-increasing compounds claimed by AHP for cardiovascular disease, dyslipoproteinemia

April 26, 1999

Hybridon describes mixed-backbone anti-MDM2 antisense oligonucleotide active in vivo

April 23, 1999

Moxonidine metabolite synthesized by Lilly and assessed in SHR

April 23, 1999

Potent and selective COX-2 inhibitors described in recent patent literature by Novartis

April 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...